Eric Santoni Rugiu

Eric Santoni Rugiu

Clinical Associate Professor

Member of:

  • Pathology


  1. 2023
  2. Published

    A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids

    Senkowski, W., Gall-Mas, L., Falco, M. M., Li, Y., Lavikka, K., Kriegbaum, M. C., Oikkonen, J., Bulanova, D., Pietras, E. J., Voßgröne, K., Chen, Y. J., Erkan, E. P., Dai, J., Lundgren, A., Grønning Høg, M. K., Larsen, I. M., Lamminen, T., Kaipio, K., Huvila, J., Virtanen, A. & 9 others, Engelholm, Lars Henning, Christiansen, P., Santoni Rugiu, Eric, Huhtinen, K., Carpén, O., Hynninen, J., Hautaniemi, S., Vähärautio, A. & Wennerberg, Krister, 2023, In: Developmental Cell. 58, 12, p. 1106-1121.e7 24 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Clinical outcomes of ALK+ non-small cell lung cancer in Denmark

    Hansen, K. H., Johansen, J. S., Urbanska, E. M., Meldgaard, P., Hjorth-Hansen, P., Kristiansen, C., Stelmach, M., Santoni Rugiu, Eric, Ulhøi, M. P., Dydensborg, A. B., Dünweber, C. & Andersen, J. L., 2023, In: Acta Oncologica. 62, 12, p. 1775-1783 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?

    Urbanska, E. M., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2023, In: Journal of Thoracic Oncology. 18, 3, p. e28-e29

    Research output: Contribution to journalLetterResearchpeer-review

  5. Published

    Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma

    Rosenberg, M. I., Greenstein, E., Buchkovich, M., Peres, A., Santoni-Rugiu, E., Yang, L., Mikl, M., Vaksman, Z., Gibbs, D. L., Reshef, D., Salovin, A., Irwin, M. S., Naranjo, A., Ulitsky, I., de Alarcon, P. A., Matthay, K. K., Weigman, V., Yaari, G., Panzer, J. A., Friedman, N. & 1 others, Maris, J. M., 2023, In: Cell Reports. 42, 8, 24 p., 112879.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC

    Urbanska, E. M., Grauslund, M., Koffeldt, P. R., Truelsen, S. L. B., Löfgren, J. O., Costa, J. C., Melchior, L. C., Sørensen, Jens Benn & Santoni Rugiu, Eric, 2023, In: International Journal of Molecular Sciences. 24, 17, 25 p., 13077.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 10801856